VisionHealth develops the Kata® app, a CE-marked digital health solution that provides real-time feedback and step-by-step guidance for patients using inhalers to manage chronic lung diseases. This technology addresses the high incidence of inhalation errors, which can lead to increased asthma attacks and hospitalizations, by optimizing the delivery of inhaled medications.
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients managing chronic respiratory diseases frequently make errors when using inhalers, leading to reduced drug delivery to the lungs. These inhalation errors can result in increased asthma attacks, hospitalizations, and a diminished quality of life.
Solution
VisionHealth's Kata® app is a CE-marked digital health solution that provides real-time feedback and step-by-step guidance to patients using inhalers. The app leverages artificial intelligence to analyze inhalation techniques and provides personalized coaching to improve drug delivery. Kata® offers a digital therapy plan with reminders, tracks patient progress, and integrates a comprehensive digital diary. By reducing inhalation errors, Kata® aims to optimize therapy effectiveness, prevent acute episodes, and enhance the overall well-being of individuals with asthma and COPD.
Target Audience
The primary target audience includes patients with asthma and COPD, as well as healthcare professionals such as pulmonologists and respiratory therapists seeking to improve patient adherence and inhalation technique.
Features
- Real-time feedback on inhalation technique, offering immediate corrections and suggestions
- Step-by-step guidance for proper inhaler usage, tailored to individual inhaler types and medications
- Digital therapy plan with personalized reminders to promote adherence
- Progress tracking and visual representation of achievements to motivate patients
- Digital diary for logging symptoms, medication usage, and other relevant health information
- Integration of artificial intelligence to analyze inhalation patterns and provide customized coaching
- Compliant with GDPR data privacy standards
- CE-marked as a Class IIa medical device